HXV project tracks down new hepatitis virus:
This article was originally published in Clinica
Genelabs Technologies (US) says it has discovered a new hepatitis virus. The find is the outcome of the company's HXV project - a collaboration with investigators at the CDC and NIH. The virus has been detected in blood from the US, Europe and Japan. The discovery has earned Genelabs - which recently terminated its non-exclusive HXV agreement with Abbott - a million-dollar milestone payment from Boehringer Mannheim.